Original Article

You have full text access to this OnlineOpen article

Cancer mortality in patients with schizophrenia

An 11-year prospective cohort study

  1. Eric Tran MD1,
  2. Frédéric Rouillon MD2,
  3. Jean-Yves Loze MD2,
  4. Françoise Casadebaig PhD3,
  5. Alain Philippe PhD3,
  6. Fabien Vitry MD4,
  7. Frédéric Limosin MD, PhD1,5,†,*

Article first published online: 22 JUN 2009

DOI: 10.1002/cncr.24383

Issue

Cancer

Cancer

Volume 115, Issue 15, pages 3555–3562, 1 August 2009

Additional Information

How to Cite

Tran, E., Rouillon, F., Loze, J.-Y., Casadebaig, F., Philippe, A., Vitry, F. and Limosin, F. (2009), Cancer mortality in patients with schizophrenia. Cancer, 115: 3555–3562. doi: 10.1002/cncr.24383

Author Information

  1. 1

    Department of Psychiatry, University of Reims, Robert Debré Hospital, Reims, France

  2. 2

    Department of Psychiatry, Sainte-Anne Hospital, University of Paris V, Paris, France

  3. 3

    National Institute of Health and Medical Research U513, University of Paris XII, Créteil, France

  4. 4

    Department of Clinical Research and Biostatistics, University of Reims, Robert Debré Hospital, Reims, France

  5. 5

    National Institute of Health and Medical Research U675, University of Paris VII, Paris, France

  1. †

    Fax: (011) 333-2678-8318

*Department of Psychiatry, University of Reims, Robert Debré Hospital, Avenue du Général Koenig, F-51092 Reims Cedex, France

Publication History

  1. Issue published online: 20 JUL 2009
  2. Article first published online: 22 JUN 2009
  3. Manuscript Accepted: 31 DEC 2008
  4. Manuscript Revised: 5 DEC 2008
  5. Manuscript Received: 18 AUG 2008

Funded by

  • General Direction of Health
  • Foundation for Medical Research

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (133K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Edward Henry Mathews, Edward Henry Mathews, Leon Liebenberg, Can successful cancer therapies build on what we learn from complex disorders?, Medical Hypotheses, 2012, 78, 5, 687

    CrossRef

  2. 2
    Nancy E. Morden, Zongshan Lai, David E. Goodrich, Todd MacKenzie, John F. McCarthy, Karen Austin, Deborah E. Welsh, Stephen Bartels, Amy M. Kilbourne, Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia, General Hospital Psychiatry, 2012,

    CrossRef

  3. 3
    Christophe E. Redon, Urbain Weyemi, Palak R. Parekh, Dejun Huang, Allison S. Burrell, William M. Bonner, γ-H2AX and other histone post-translational modifications in the clinic, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2012,

    CrossRef

  4. 4
    Siran M. Koroukian, Paul M. Bakaki, Negar Golchin, Carl Tyler, Sana Loue, Mental Illness and Use of Screening Mammography Among Medicaid Beneficiaries, American Journal of Preventive Medicine, 2012, 42, 6, 606

    CrossRef

  5. 5
    Y. Tada, M. Matsubara, S. Kawada, M. Ishida, M. Wada, T. Wada, H. Onishi, Psychiatric Disorders in Cancer Patients at a University Hospital in Japan: Descriptive Analysis of 765 Psychiatric Referrals, Japanese Journal of Clinical Oncology, 2012, 42, 3, 183

    CrossRef

  6. 6
    Frédéric Limosin, Schizophrénie et vieillissement, Annales Médico-psychologiques, revue psychiatrique, 2012, 170, 4, 275

    CrossRef

  7. 7
    Vicki L. Ellingrod, Stephan F. Taylor, Robert D. Brook, Simon J. Evans, Sebastian K. Zöllner, Tyler B. Grove, Kristen M. Gardner, Michael J. Bly, Rodica Pop-Busui, Gregory Dalack, Dietary, lifestyle and pharmacogenetic factors associated with arteriole endothelial-dependent vasodilatation in schizophrenia patients treated with atypical antipsychotics (AAPs), Schizophrenia Research, 2011, 130, 1-3, 20

    CrossRef

  8. 8
    Yang Wang, Guang He, Lin He, John McGrath, Do shared mechanisms underlying cell cycle regulation and synaptic plasticity underlie the reduced incidence of cancer in schizophrenia?, Schizophrenia Research, 2011, 130, 1-3, 282

    CrossRef

  9. 9
    Anne Høye, Bjarne K. Jacobsen, Vidje Hansen, Increasing mortality in schizophrenia: Are women at particular risk? A follow-up of 1111 patients admitted during 1980–2006 in Northern Norway, Schizophrenia Research, 2011, 132, 2-3, 228

    CrossRef

  10. 10
    Po-Hsiu Kuo, Chung-Feng Kao, Po-Yu Chen, Chun-Hsin Chen, Yau-Sheng Tsai, Mong-Lian Lu, Ming-Chyi Huang, Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic Patients, Journal of Clinical Psychopharmacology, 2011, 31, 6, 705

    CrossRef

  11. You have free access to this content11
    M. V. Seeman, Preventing breast cancer in women with schizophrenia, Acta Psychiatrica Scandinavica, 2011, 123, 2
    Direct Link:
  12. 12
    Louise M Howard, Elizabeth A Barley, Elizabeth Davies, Anne Rigg, Heidi Lempp, Diana Rose, David Taylor, Graham Thornicroft, Cancer diagnosis in people with severe mental illness: practical and ethical issues, The Lancet Oncology, 2010, 11, 8, 797

    CrossRef

  13. 13
    F. Limosin, Cancer et schizophrénie : données épidémiologiques et hypothèses étiopathogéniques, Psycho-Oncologie, 2010, 4, 1, 7

    CrossRef

  14. 14
    Thomas J Raedler, Cardiovascular aspects of antipsychotics, Current Opinion in Psychiatry, 2010, 23, 6, 574

    CrossRef

  15. 15
    Health, Health Care and the Right to Health,
    Direct Link:
  16. 16
    Iain Kooyman, Elizabeth Walsh, Societal Outcomes in Schizophrenia,
    Direct Link:
View Full Article (HTML) Get PDF (133K)